Nippon India Pharma Fund(G)

191.24 0.15 (0.08%) NAV as on 05-Jun-20
52-Week High ( ) 191.24 (05-Jun-20)
52-Week Low ( ) 130.37 (23-Mar-20)
Type Open ended scheme
Launch Date 05-Jun-04
Net Assets ( Cr ) 2492.35
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 5000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return26.4533.1615.5020.24
Category Avg24.0632.419.9017.33
Category Best-0.765.063.2019.46
Category Worst-6.89-3.39-6.39-4.00
SENSEX-15.92-14.463.07-
BSE HC19.9421.565.23-
NIFTY-15.61-15.631.58-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Aurobindo Pharma LimitedDomestic Equities10.98
Dr. Reddy's Laboratories LimitedDomestic Equities10.36
Sun Pharmaceutical Industries LimitedDomestic Equities10.27
Divi's Laboratories LimitedDomestic Equities9
Cipla LimitedDomestic Equities7.86
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equity and Equity related Instruments of companies in Pharma Sector80100
Debt & MMI020
Units issued by REITs and InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 05/06/2020 As on 05/06/2020

10142.15 (1.13) 34287.24 (0.90)

TOP GAINERS

Company Price Change Gain (%)
Visagar Polytex0.250.0525.00
Vodafone Idea10.501.9022.09

TOP LOSERS

Company Price Change Loss (%)
Euro Multivision0.40-0.05-11.11
Chemfab Alkalis139.95-9.90-6.61

Portfolio Comparison

MUTUAL FUND ACTIVITY